Charter Trust Co. trimmed its holdings in shares of Omega Healthcare Investors Inc (NYSE:OHI) by 58.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,623 shares of the real estate investment trust’s stock after selling 15,170 shares during the quarter. Charter Trust Co.’s holdings in Omega Healthcare Investors were worth $282,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the stock. US Bancorp DE increased its position in shares of Omega Healthcare Investors by 0.9% during the fourth quarter. US Bancorp DE now owns 27,826 shares of the real estate investment trust’s stock valued at $1,178,000 after acquiring an additional 257 shares during the last quarter. Oakbrook Investments LLC increased its holdings in shares of Omega Healthcare Investors by 2.5% in the fourth quarter. Oakbrook Investments LLC now owns 12,150 shares of the real estate investment trust’s stock worth $515,000 after buying an additional 300 shares during the period. BerganKDV Wealth Management LLC increased its holdings in shares of Omega Healthcare Investors by 11.4% in the fourth quarter. BerganKDV Wealth Management LLC now owns 3,597 shares of the real estate investment trust’s stock worth $152,000 after buying an additional 367 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of Omega Healthcare Investors by 1.1% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 38,540 shares of the real estate investment trust’s stock worth $1,632,000 after buying an additional 412 shares during the period. Finally, Capital Investment Advisory Services LLC increased its holdings in shares of Omega Healthcare Investors by 6.2% in the first quarter. Capital Investment Advisory Services LLC now owns 7,746 shares of the real estate investment trust’s stock worth $206,000 after buying an additional 454 shares during the period. 70.26% of the stock is owned by institutional investors.
Shares of NYSE OHI traded down $2.33 during trading hours on Thursday, hitting $30.30. The company’s stock had a trading volume of 79,926 shares, compared to its average volume of 2,631,672. The company has a debt-to-equity ratio of 1.31, a quick ratio of 3.93 and a current ratio of 3.93. The stock has a market cap of $7.12 billion, a price-to-earnings ratio of 18.66, a P/E/G ratio of 6.35 and a beta of 0.91. Omega Healthcare Investors Inc has a 12 month low of $13.33 and a 12 month high of $45.22. The business has a 50-day simple moving average of $29.06 and a 200-day simple moving average of $35.98.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.39 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.03). The firm had revenue of $253.00 million for the quarter, compared to the consensus estimate of $217.97 million. Omega Healthcare Investors had a net margin of 37.71% and a return on equity of 8.66%. The business’s revenue was up 34.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 earnings per share. On average, equities research analysts forecast that Omega Healthcare Investors Inc will post 3.04 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Thursday, April 30th were given a dividend of $0.67 per share. The ex-dividend date was Wednesday, April 29th. This represents a $2.68 annualized dividend and a yield of 8.84%. Omega Healthcare Investors’s payout ratio is 87.30%.
OHI has been the topic of several analyst reports. lifted their price objective on Omega Healthcare Investors to $26.54 and gave the stock a “sell” rating in a report on Tuesday. SunTrust Banks decreased their price objective on Omega Healthcare Investors from $36.00 to $32.00 and set a “hold” rating on the stock in a report on Thursday, April 23rd. Scotiabank upgraded Omega Healthcare Investors from a “sector perform” rating to a “sector outperform” rating and set a $37.00 price objective on the stock in a report on Wednesday, April 8th. JMP Securities initiated coverage on Omega Healthcare Investors in a report on Monday. They issued a “market perform” rating on the stock. Finally, Wells Fargo & Co decreased their price objective on Omega Healthcare Investors from $43.00 to $28.00 and set an “equal weight” rating on the stock in a report on Thursday, March 26th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Omega Healthcare Investors presently has a consensus rating of “Hold” and an average target price of $34.32.
In other news, Director Craig R. Callen acquired 5,000 shares of the business’s stock in a transaction on Monday, March 16th. The shares were acquired at an average cost of $17.68 per share, with a total value of $88,400.00. Also, CAO Michael Ritz sold 2,250 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $35.00, for a total value of $78,750.00. The disclosure for this sale can be found here. Insiders own 1.16% of the company’s stock.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Recommended Story: Gross Domestic Product (GDP)
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.